MedTrace Logo

LifeVest Safety and Efficacy in Real Life Settings in France

NCT03319160 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1164

Last updated 2024-12-09

Study results available
· View outcomes & findings →

Summary

This post-market study is a prospective observational study evaluating the efficacy and safety of the LifeVest in real-life settings.

Conditions

Interventions

DEVICE

Wearable Cardioverter Defibrillator

A non-invasive wearable cardioverter defibrillator detects and treats VT/VF without the need for bystander intervention

Sponsors & Collaborators

  • Zoll Medical Corporation

    lead INDUSTRY

Principal Investigators

  • Steve Szymkiewicz, MD · Zoll Medical Corporation

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-02
Primary Completion
2018-09-30
Completion
2019-03-30
FDA Device
Yes

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03319160 on ClinicalTrials.gov